About the VMI/PACCM Innovation & Entrepreneurship Program
Simplify and demystify aspects of commercialization for scientists and investigators at PACCM and VMI
Enable and optimize the commercialization and innovation of investigator discoveries
- Advisement to investigators in PACCM & VMI with the process of academic commercialization
- Facilitate interaction with key stakeholders that enable commercialization at the University of Pittsburgh
- Strategize for innovation/commercialization grants
Innovation Consulting
Resources
Starting a Business: Navigating Commercialization at Pitt
Jason Rose, MD, MBA
Evan Facher, PhD, MBA
limited access
Commercialization at Pitt: a case study and navigating the innovation ecosystem
01/2022
Jason Rose, MD, MBA
Peter Allen, PhD
limited access
Funding Opportunities
Chancellor's Gap Fund
Due Date: 09/24/2021
Eligibility: Pitt Faculty and Trainees
Program Announcement
Program Contact: Peter Allen
Advisement on opportunity
Pitt Innovation Challenge
Due Date: 06/24/2021
Eligibility: Pitt Faculty and Trainees
Program Announcement
Program Contact: Mike Flock
Advisement on opportunity
Pitt Ventures First Gear
NSF I-Corps program that helps shape Pitt inventions originating from University research from early-stage discoveries into products and services that can be taken to market
SBIR STTR Workshop at the University of Pittsburgh
Webinar on SBIR/STTR Program given at the University of Pittsburgh in 2019
Program Leadership
Director: Jason J Rose, MD, MBA
- Assistant Professor of Medicine and Bioengineering
- Research focus inhaltional toxins and drug development
- Co-founder of two life science startups
- Co-inventor on multiple patents, patent applications and invention disclosures
- Co-PI on Phase I/II Fast Track STTR Grant from NIH to Pitt and Globin Solutions
Administrator: Annie Watson
- Clinical Research Coordinator, Chan Lab
- Experience in bench research and genetics
- Completed MPH from University of Pittsburgh
- Works on development of novel therapies for pulmonary hypertension
- Translational clinical trials